Abstract
To the Editor: I read with great interest the article by Rafael-Fortney et al1 about the effect of early treatment with lisinopril and spironolactone on cardiac and skeletal muscle in Duchenne muscular dystrophy mice. This article raised the concerns stated below. The authors have …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
